Bioceres Crop Solutions (NASDAQ:BIOX) Shares Up 4.8% – Should You Buy?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX)’s stock price shot up 4.8% during trading on Monday . The company traded as high as $0.3989 and last traded at $0.3897. 283,297 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 1,536,495 shares. The stock had previously closed at $0.3720.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Canaccord Genuity Group lowered their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a report on Friday, January 2nd. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $4.00.

Bioceres Crop Solutions Trading Up 4.8%

The firm’s 50 day simple moving average is $0.72 and its 200-day simple moving average is $1.31. The company has a market capitalization of $24.64 million, a PE ratio of -0.10 and a beta of 0.53. The company has a quick ratio of 0.69, a current ratio of 0.90 and a debt-to-equity ratio of 0.32.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its earnings results on Friday, March 13th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). The business had revenue of $73.67 million during the quarter, compared to analysts’ expectations of $104.55 million. Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%. As a group, equities research analysts anticipate that Bioceres Crop Solutions Corp. will post -0.05 EPS for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of large investors have recently modified their holdings of the stock. Invesco Ltd. purchased a new stake in shares of Bioceres Crop Solutions during the 4th quarter valued at about $45,000. Ardsley Advisory Partners LP grew its position in Bioceres Crop Solutions by 691.7% in the fourth quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock valued at $622,000 after acquiring an additional 415,000 shares in the last quarter. GAM Holding AG purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter valued at approximately $655,000. State of Wisconsin Investment Board purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter valued at approximately $247,000. Finally, Marshall Wace LLP lifted its position in shares of Bioceres Crop Solutions by 180.0% during the fourth quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock worth $780,000 after purchasing an additional 382,744 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.